Evidence map›Paper›PMID 15958742›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2005

The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation.

Caroline R Sussman, Timothy Vartanian, Robert H Miller

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.Neuropathology : official journal of the Japanese Society of Neuropathology · 2019
    Article
  10. Article
  11. Review
  12. Review
  13. Cyclin-dependent kinase 5 mediates adult OPC maturation and myelin repair through modulation of Akt and GsK-3β signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Signals to promote myelin formation and repair.Nature reviews. Neurology · 2010
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Caroline R SussmanDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106-4965, USA. caroline.sussman@case.edu
Timothy Vartanian
Robert H Miller
Case Western Reserve University · US

Funding

Development of Oligodendrycytes in the Spinal CordR01NS030800 · NINDS · GEORGE WASHINGTON UNIVERSITY · PI MILLER, ROBERT H. · 1995 to 2018
$5.7M
NINDS NIH HHS NS 30800NINDS NIH HHS NS 42317
6 · The paper itself

Abstract

Neuregulin is required for proper oligodendrocyte development, but which receptors are involved and whether neuregulin promotes or inhibits maturation remain controversial. To assess the roles of the neuregulin receptor ErbB4 in oligodendrocyte development, we examined oligodendrocyte initiation and maturation in cultures derived from erbB4 knock-out mice and rat spinal cord in the presence of neutralizing erbB4 antibodies. No differences in the development of O4+ oligodendrocytes were detected in the presence or absence of erbB4 signaling. All four epidermal growth factor receptor family members were detected in the ventral neural tube at approximately the time of initial oligodendrocyte development, consistent with redundancy in neuregulin receptor signaling at the onset of oligodendrocyte development. In contrast, greater numbers of differentiated (monoclonal antibody O1+) oligodendrocytes developed in neural tube explants from erbB4(-/-) mice than either erbB4(+/+) or erbB4(+/-) littermates as well as in cultures treated with anti-erbB4. These data indicate that ErbB4 is not required for oligodendrocyte development and, in fact, inhibits oligodendrocyte lineage maturation. Together with previous studies, these data suggest a model in which early oligodendrocyte lineage development is regulated by promiscuous neuregulin receptor signaling, but subsequent lineage progression occurs through a balance of receptor-specific promotion or inhibition of maturation.

Indexed as

AnimalsBase SequenceCells, CulturedDNA PrimersEmbryo, MammalianErbB ReceptorsGene Expression Regulation, DevelopmentalImmunohistochemistryMiceMice, KnockoutNervous SystemOligodendrogliaRatsReceptor, ErbB-4Reverse Transcriptase Polymerase Chain ReactionSpinal CordDNA PrimersErbb4 protein, mouseErbb4 protein, ratErbB ReceptorsReceptor, ErbB-4

Identifiers

PMID15958742
PMCPMC6724872
OpenAlexW1976828312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.